Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386530973> ?p ?o ?g. }
- W4386530973 endingPage "256" @default.
- W4386530973 startingPage "249" @default.
- W4386530973 abstract "This study aims to investigate proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis (d-SSc) and its relation to disease activity, severity and subclinical atherosclerosis in such group of patients.Between December 2019 and July 2021, a total of 41 patients with d-SSc (17 males, 24 females; mean age: 36.1±1.9 years; range, 19 to 58 years) and 41- age and sex-matched healthy controls (17 males, 24 females; mean age: 40.1±1.7 years; range, 20 to 60 years) were included. Disease activity and skin thickness of the patients were evaluated using the European Scleroderma Study Group (EScSG) score and modified Rodnan skin score (mRSS), respectively. Serum PCSK9 and carotid intima-media thickness (CIMT) were measured using enzyme-linked immunosorbent assay (ELISA) and Duplex ultrasound, respectively.Serum PCSK9 was higher in patients compared to controls (p=0.003), particularly in those with digital ulcer (DU) and interstitial lung disease (ILD) (p<0.001). The PCSK9 positively correlated with the mean pulmonary artery pressure, EScSG, mRSS, C-reactive protein (p<0.001), erythrocyte sedimentation rate (p<0.05), lipid profile, and mean CIMT (p<0.01). In the multivariate analysis, EScSG, mRSS, lipid profile, and waist circumference were significantly correlated with PCSK9. Serum PCSK9 levels of (182.6 ng/mL) had 77.7% sensitivity and 81.2% specificity for diagnosing DU versus (172.8 ng/mL) 90.1% and 73.5% for ILD (p<0.001).Serum PCSK9 is upregulated in d-SSc with higher levels in severe disease manifestations such as DU and ILD. It is correlated well with disease activity, more severe disease manifestations, and CIMT. The PCSK9 inhibitors may be a target of therapy in diseases with premature atherosclerosis such as d-SSc regardless of its anti-cholesterol effect, at least in more severe manifestations." @default.
- W4386530973 created "2023-09-09" @default.
- W4386530973 creator A5029909569 @default.
- W4386530973 creator A5069719894 @default.
- W4386530973 creator A5073168104 @default.
- W4386530973 creator A5076264281 @default.
- W4386530973 date "2023-06-01" @default.
- W4386530973 modified "2023-09-27" @default.
- W4386530973 title "Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations." @default.
- W4386530973 cites W1540350711 @default.
- W4386530973 cites W1888435097 @default.
- W4386530973 cites W1909939624 @default.
- W4386530973 cites W1947440606 @default.
- W4386530973 cites W1976887141 @default.
- W4386530973 cites W1977653097 @default.
- W4386530973 cites W1987901476 @default.
- W4386530973 cites W1990237691 @default.
- W4386530973 cites W2001927754 @default.
- W4386530973 cites W2067539811 @default.
- W4386530973 cites W2071154679 @default.
- W4386530973 cites W2086048382 @default.
- W4386530973 cites W2090565167 @default.
- W4386530973 cites W2099050243 @default.
- W4386530973 cites W2099699365 @default.
- W4386530973 cites W2112345742 @default.
- W4386530973 cites W2134423316 @default.
- W4386530973 cites W2146781900 @default.
- W4386530973 cites W2149024872 @default.
- W4386530973 cites W2159064184 @default.
- W4386530973 cites W2163154920 @default.
- W4386530973 cites W2163215334 @default.
- W4386530973 cites W2164096595 @default.
- W4386530973 cites W2164103877 @default.
- W4386530973 cites W2166900112 @default.
- W4386530973 cites W2171371748 @default.
- W4386530973 cites W2496167568 @default.
- W4386530973 cites W2589893823 @default.
- W4386530973 cites W2609836833 @default.
- W4386530973 cites W2770660828 @default.
- W4386530973 cites W2900011322 @default.
- W4386530973 cites W2944082641 @default.
- W4386530973 cites W2955932804 @default.
- W4386530973 cites W2982588127 @default.
- W4386530973 cites W3017667348 @default.
- W4386530973 cites W3109176657 @default.
- W4386530973 cites W3112613216 @default.
- W4386530973 cites W3122285895 @default.
- W4386530973 cites W569183658 @default.
- W4386530973 doi "https://doi.org/10.46497/archrheumatol.2023.9638" @default.
- W4386530973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37680510" @default.
- W4386530973 hasPublicationYear "2023" @default.
- W4386530973 type Work @default.
- W4386530973 citedByCount "0" @default.
- W4386530973 crossrefType "journal-article" @default.
- W4386530973 hasAuthorship W4386530973A5029909569 @default.
- W4386530973 hasAuthorship W4386530973A5069719894 @default.
- W4386530973 hasAuthorship W4386530973A5073168104 @default.
- W4386530973 hasAuthorship W4386530973A5076264281 @default.
- W4386530973 hasConcept C126322002 @default.
- W4386530973 hasConcept C142724271 @default.
- W4386530973 hasConcept C180032290 @default.
- W4386530973 hasConcept C2777543607 @default.
- W4386530973 hasConcept C2777714996 @default.
- W4386530973 hasConcept C2778143017 @default.
- W4386530973 hasConcept C2778163477 @default.
- W4386530973 hasConcept C2778270857 @default.
- W4386530973 hasConcept C2779967694 @default.
- W4386530973 hasConcept C2780072125 @default.
- W4386530973 hasConcept C2780948078 @default.
- W4386530973 hasConcept C43554185 @default.
- W4386530973 hasConcept C71924100 @default.
- W4386530973 hasConcept C90924648 @default.
- W4386530973 hasConceptScore W4386530973C126322002 @default.
- W4386530973 hasConceptScore W4386530973C142724271 @default.
- W4386530973 hasConceptScore W4386530973C180032290 @default.
- W4386530973 hasConceptScore W4386530973C2777543607 @default.
- W4386530973 hasConceptScore W4386530973C2777714996 @default.
- W4386530973 hasConceptScore W4386530973C2778143017 @default.
- W4386530973 hasConceptScore W4386530973C2778163477 @default.
- W4386530973 hasConceptScore W4386530973C2778270857 @default.
- W4386530973 hasConceptScore W4386530973C2779967694 @default.
- W4386530973 hasConceptScore W4386530973C2780072125 @default.
- W4386530973 hasConceptScore W4386530973C2780948078 @default.
- W4386530973 hasConceptScore W4386530973C43554185 @default.
- W4386530973 hasConceptScore W4386530973C71924100 @default.
- W4386530973 hasConceptScore W4386530973C90924648 @default.
- W4386530973 hasIssue "2" @default.
- W4386530973 hasLocation W43865309731 @default.
- W4386530973 hasOpenAccess W4386530973 @default.
- W4386530973 hasPrimaryLocation W43865309731 @default.
- W4386530973 hasRelatedWork W1932542775 @default.
- W4386530973 hasRelatedWork W1977299683 @default.
- W4386530973 hasRelatedWork W1996248520 @default.
- W4386530973 hasRelatedWork W2096435127 @default.
- W4386530973 hasRelatedWork W2376405497 @default.
- W4386530973 hasRelatedWork W2425124226 @default.
- W4386530973 hasRelatedWork W2429333288 @default.
- W4386530973 hasRelatedWork W2765985895 @default.